文献速递生殖医学

对无精子症男性进行基于小鼠无精子症基因面板的测序:鉴定RNF212和STAG3突变作为减数分裂停滞的新遗传原因

Sequencing of a 'mouse azoospermia' gene panel in azoospermic men: identification of RNF212 and STAG3 mutations as novel genetic causes of meiotic arrest.
PubMed 文献 · Hum Reprod · 2019-01-01

本研究基于小鼠无精子症相关基因设计175基因面板,对33例特发性非梗阻性无精子症(NOA)患者进行二代测序,在1例散发患者和2例兄弟患者中分别发现STAG3双等位基因变异和RNF212纯合变异,所有3例携带者均表现为减数分裂停滞。功能研究揭示了这些突变在人类男性减数分裂中的作用。

要点

  • 基于小鼠无精子症基因面板的测序在特发性NOA患者中诊断成功率相对较高。
  • 发现STAG3双等位基因变异和RNF212纯合变异是NOA伴减数分裂停滞的新遗传原因。
  • 作者建议将RNF212和STAG3纳入未来的男性不育诊断基因面板。

核心结论

  • 基于小鼠无精子症基因面板的测序在特发性NOA患者中诊断性能相对成功,并发现了两个与减数分裂停滞所致NOA相关的新基因。

研究设计与样本

  • 研究分四步:首先通过查询小鼠基因组信息学数据库(MGI)设计「小鼠无精子症」基因面板;其次对33例高度选择的特发性NOA患者进行175个基因的二代测序(NGS);第三利用携带RNF212和STAG3致病性变异者的剩余睾丸活检组织进行减数分裂研究;最后在不同组织学睾丸活检中分析RNF212和STAG3表达。
  • 从总共1300例不育患者中分析33例特发性NOA患者,包括31例无血缘关系男性和一个近亲家系中的2例兄弟。
  • 31例无血缘关系NOA患者的睾丸组织学为:20例唯支持细胞综合征(SCOS),11例生精停滞(6例精原细胞停滞和5例精母细胞停滞);两兄弟患有精母细胞停滞。

主要发现

  • 该方案导致1例散发NOA患者和2例NOA兄弟的遗传诊断。
  • 所有3例突变携带者均表现为减数分裂停滞,在7例具有该特定睾丸表型的病例中实现了3例的遗传诊断。
  • 首次报道1例散发患者中的STAG3双等位基因变异和两兄弟中的RNF212纯合变异作为NOA的遗传原因。
  • 减数分裂研究检测到突变的功能后果,并提供了STAG3和RNF212在人类男性减数分裂中作用的信息。

临床怎么用

  • 作者提出将RNF212和STAG3纳入未来的男性不育诊断基因面板。
  • 基于相关的睾丸表型,这些基因中致病突变的鉴定对睾丸精子提取具有阴性预测价值。
  • 作者认为遗传咨询应不仅涉及男性NOA患者,还应涉及其女性亲属。

局限性

  • 在约一半的精母细胞停滞患者中确定了遗传原因。
  • 分析的 patient 数量少可被视为一个局限性,但该睾丸表型非常罕见。
  • 由于该特定表型在不育男性中频率低,本发现可能被认为临床影响低;然而在个体水平,其对睾丸精子提取前的预后判断具有相关性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: What is the diagnostic potential of next generation sequencing (NGS) based on a 'mouse azoospermia' gene panel in human non-obstructive azoospermia (NOA)? SUMMARY ANSWER: The diagnostic performance of sequencing a gene panel based on genes associated with mouse azoospermia was relatively successful in idiopathic NOA patients and allowed the discovery of two novel genes involved in NOA due to meiotic arrest. WHAT IS KNOWN ALREADY: NOA is a largely heterogeneous clinical entity, which includes different histological pictures. In a large proportion of NOA, the aetiology remains unknown (idiopathic NOA) and yet, unknown genetic factors are likely to play be involved. The mouse is the most broadly used mammalian model for studying human disease because of its usefulness for genetic manipulation and its genetic and physiological similarities to man. Mouse azoospermia models are available in the Mouse Genome Informatics database (MGI: http://www.informatics.jax.org/). STUDY DESIGN, SIZE, DURATION: The first step was to design of a 'mouse azoospermia' gene panel through the consultation of MGI. The second step was NGS analysis of 175 genes in a group of highly selected NOA patients (n = 33). The third step was characterization of the discovered gene defects in human testis tissue, through meiotic studies using surplus testicular biopsy material from the carriers of the RNF212 and STAG3 pathogenic variants. The final step was RNF212 and STAG3 expression analysis in a collection of testis biopsies. PARTICIPANTS/MATERIALS, SETTING, METHODS: From a total of 1300 infertile patients, 33 idiopathic NOA patients were analysed in this study, including 31 unrelated men and 2 brothers from a consanguineous family. The testis histology of the 31 unrelated NOA patients was as follows: 20 Sertoli cell-only syndrome (SCOS), 11 spermatogenic arrest (6 spermatogonial arrest and 5 spermatocytic arrest). The two brothers were affected by spermatocytic arrest. DNA extracted from blood was used for NGS on Illumina NextSeq500 platform. Generated sequence data was filtered for rare and potentially pathogenic variants. Functional studies in surplus testicular tissue from the carriers included the investigation of meiotic entry, XY body formation and metaphases by performing fluorescent immunohistochemical staining and immunocytochemistry. mRNA expression analysis through RT-qPCR of RNF212 and STAG3 was carried out in a collection of testis biopsies with different histology. MAIN RESULTS AND THE ROLE OF CHANCE: Our approach was relatively successful, leading to the genetic diagnosis of one sporadic NOA patient and two NOA brothers. This relatively high diagnostic performance is likely to be related to the stringent patient selection criteria i.e. all known causes of azoospermia were excluded and to the relatively high number of patients with rare testis histology (spermatocytic arrest). All three mutation carriers presented meiotic arrest, leading to the genetic diagnosis of three out of seven cases with this specific testicular phenotype. For the first time, we report biallelic variants in STAG3, in one sporadic patient, and a homozygous RNF212 variant, in the two brothers, as the genetic cause of NOA. Meiotic studies allowed the detection of the functional consequences of the mutations and provided information on the role of STAG3 and RNF212 in human male meiosis. LIMITATIONS, REASONS FOR CAUTION: All genes, with the exception of 5 out of 175, included in the panel cause azoospermia in mice only in the homozygous or hemizygous state. Consequently, apart from the five known dominant genes, heterozygous variants (except compound heterozygosity) in the remaining genes were not taken into consideration as causes of NOA. We identified the genetic cause in approximately half of the patients with spermatocytic arrest. The low number of analysed patients can be considered as a limitation, but it is a very rare testis phenotype. Due to the low frequency of this specific phenotype among infertile men, our finding may be considered of low clinical impact. However, at an individual level, it does have relevance for prognostic purposes prior testicular sperm extraction. WIDER IMPLICATIONS OF THE FINDINGS: Our study represents an additional step towards elucidating the genetic bases of early spermatogenic failure, since we discovered two new genes involved in human male meiotic arrest. We propose the inclusion of RNF212 and STAG3 in a future male infertility diagnostic gene panel. Based on the associated testis phenotype, the identification of pathogenic mutations in these genes also confers a negative predictive value for testicular sperm retrieval. Our meiotic studies provide novel insights into the role of these proteins in human male meiosis. Mutations in STAG3 were first described as a cause of female infertility and ovarian cancer, and Rnf212 knock out in mice leads to male and female infertility. Hence, our results stimulate further research on shared genetic factors causing infertility in both sexes and indicate that genetic counselling should involve not only male but also female relatives of NOA patients. STUDY FUNDING/COMPETING INTEREST(S): This work was funded by the Spanish Ministry of Health Instituto Carlos III-FIS (grant number: FIS/FEDER-PI14/01250; PI17/01822) awarded to CK and AR-E, and by the European Commission, Reproductive Biology Early Research Training (REPROTRAIN, EU-FP7-PEOPLE-2011-ITN289880), awarded to CK, WB, and AE-M. The authors have no conflict of interest.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Riera-Escamilla A, Enguita-Marruedo A, Moreno-Mendoza D, et al. Sequencing of a 'mouse azoospermia' gene panel in azoospermic men: identification of RNF212 and STAG3 mutations as novel genetic causes of meiotic arrest. Hum Reprod. 2019. PMID: 31125047. doi:10.1093/humrep/dez042

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。